Puro Risk Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
Massachusetts THC Potency Audits Turn Label Accuracy Into A Shelf Risk
Massachusetts regulators are beginning THC potency audits for retail cannabis products, and products testing outside the allowed range may be removed from shelves. The bigger lesson is that potency claims are now a real compliance and enforcement issue for operators across the supply chain.
Delaware Hemp THC Regulation Fight Could Reshape Who Gets To Sell
Delaware lawmakers are weighing four hemp THC bills that could decide whether intoxicating hemp products stay in smoke shops or move into licensed cannabis channels. The bigger lesson is that product testing, labeling, age restrictions, and enforcement exposure are becoming real business issues now.
Massachusetts Cannabis Commission Reform Signals A New Regulatory Phase
Massachusetts Gov. Maura Healey appointed three new Cannabis Control Commission members after reforms reduced the commission from five members to three. The bigger lesson is that operators should watch licensing, enforcement priorities, retail limits, and future rulemaking as the state rebuilds its cannabis regulator.
Virginia Adult Use Cannabis Retail Launch Delayed Again After Governor Veto
Virginia’s adult use cannabis retail launch is delayed again after Gov. Abigail Spanberger vetoed legislation that would have opened the market. The bigger lesson is that legal possession still does not equal real market access for operators, investors, landlords, or lenders.
Minnesota Cannabis Bill Shows Market Rules Are Still Moving
Minnesota lawmakers advanced an omnibus cannabis bill that would replace the medical combination license with a new macrobusiness license, reduce canopy limits, create a ratio hemp infused product category, and give hemp businesses a path toward cannabis licensing. The bigger lesson is that market access, supply planning, and license strategy can change before a cannabis market fully matures.
Georgia Medical Cannabis Expansion Creates A More Serious Limited License Market
Georgia’s Senate Bill 220 expands the state’s medical cannabis program by allowing vaping, adding qualifying conditions, and replacing the former THC cap with a possession limit. The bigger lesson is that Georgia is creating a more serious medical market while keeping a tightly controlled limited license structure.
Oklahoma Turns DEA Registration Into A Real State Compliance Deadline
Oklahoma is turning DEA registration from a possible federal strategy into a real state compliance issue for medical cannabis manufacturers and distributors. The bigger lesson for operators is that state permit risk, 280E planning, and banking access may now all depend on how quickly they respond.
DEA Schedule III Registration Is Starting To Look Like A Federal Maze
The DEA is preparing a separate Schedule III registration path for cultivators, manufacturers, distributors, and testing labs, showing that rescheduling is becoming a real compliance process. The bigger lesson is that operators now need to think about forms, fees, ownership questions, and federal exposure instead of treating Schedule III like automatic relief.
DEA Position On Lab Derived Cannabinoids Raises Pressure Across The Hemp Market
The DEA’s renewed position on lab derived cannabinoids is raising pressure across the hemp market, especially for businesses tied to HHC, delta 8, THCP, and similar converted products. The bigger lesson for operators is that inventory, contracts, payment relationships, and compliance records need tighter review now.
Idaho Medical Cannabis Push Creates An Early Market Positioning Window
Idaho medical cannabis supporters submitted more than 150,000 signatures for a 2026 ballot proposal, creating real momentum for a tightly regulated medical market. The bigger lesson for operators is that limited license opportunities reward early positioning, local relationships, and compliance planning before the market officially opens.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to review your cannabis coverage?
Call us on (323)905-3396
or growth@cannashield.io

Trulieve and Cronos have each gained roughly 27 percent in 2026 while reporting stronger operating results. The broader signal is that public market attention is increasingly rewarding cash generation, improving margins, liquidity, and measurable revenue growth.